Relay Therapeutics(RLAY.US)

Last Updated 19:00:00 ET
longbridge loading

Relay Therapeutics Reports Early Success For Investigational Drug In Rare Vascular Disorders

benzinga_article·
US
RLAY
-0.25%
benzinga_article·
US
RLAY
-0.25%

Relay Therapeutics shares are trading higher after the company announced initial clinical data from the Phase 2 ReInspire trial of zovegalisib in vascular anomalies signaling the advantage of PI3Kα mutant-selective inhibition.

benzinga_article·
US
RLAY
-0.25%
US
PBE
+0.11%
US
VHT
+0.97%
benzinga_article·
US
RLAY
-0.25%
US
PBE
+0.11%
US
VHT
+0.97%

This Biotech's Drug Just Wiped The Floor With Forecasts

Unusual Whales·
US
RLAY
-0.25%
US
XBI
-0.69%
US
PBE
+0.11%
Unusual Whales·
US
RLAY
-0.25%
US
XBI
-0.69%
US
PBE
+0.11%
© 2026 Longbridge｜Disclaimer